Caspofungin dosage adjustments are not required for patients with Child–Pugh B or C cirrhosis
Thierry Gustot(Université Libre de Bruxelles), Roger J. M. Brüggemann(Radboud University Nijmegen), Rob ter Heine(Radboud University Nijmegen), Elisa Brauns(Erasmus Hospital), Frédéric Cotton(Université Libre de Bruxelles), Frédérique Jacobs(Université Libre de Bruxelles)
Cited by 19
Related Papers
Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial
|The Lancet|2007|689
Severe sepsis in cirrhosis†
|Hepatology|2009|446
Deep Dermatophytosis and Inherited CARD9 Deficiency
|New England Journal of Medicine|2013|403
The interleukin-17 pathway is involved in human alcoholic liver disease # †
|Hepatology|2008|385
Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock
|Critical Care|2010|372